Aspirin News and Research

RSS

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.

SDSU researchers show cancer-inhibiting potential of flavonoid metabolite

Eating fruits and vegetables is more important than ever.

2 Dec 2019

Medicinal plants: from genes to drugs

We eat plants, wear their products, burn them for fuel, and use them to build our houses. Plants are the very basis of the food chain on earth. They are also the source of oxygen in the atmosphere, and a treasure house containing a host of compounds that have biological effects on the body. Some of these chemicals are produced as self-defence, to guard against pests and diseases.

27 Nov 2019

VA evaluates the effect of opioids, sedatives on veterans

Veterans who simultaneously take opioids for chronic pain and benzodiazepines for anxiety and insomnia are at an increased risk of unintentional overdose and death as well as suicide.

6 Nov 2019

Researchers investigate whether aspirin can decrease rate of intracranial aneurysm growth

Researchers conducted a database search to investigate whether aspirin can aid in the prevention of intracranial aneurysm rupture by hindering aneurysm growth. The researchers identified 146 patients harboring multiple intracranial aneurysms, five millimeters or less in diameter, that had been observed for at least five years.

29 Oct 2019

Anti-inflammatory agents can safely, effectively reduce symptoms of major depression

Anti-inflammatory agents, such as aspirin/paracetamol, statins, and antibiotics, can safely and effectively curb the symptoms of major depression, finds a pooled analysis of the available evidence, published online in the Journal of Neurology Neurosurgery & Psychiatry.

29 Oct 2019

Study aims to learn more about silent infarction, cognitive decline linked to silent stroke

Can you have a stroke and not know it? Unfortunately, yes. It is a phenomenon called a silent stroke or, more formally, a silent cerebral infarction. Investigators at the University of Alabama at Birmingham and Stanford University want to learn more about silent strokes and their role in brain health, including dementia.

24 Oct 2019

Rapamycin is more effective at slowing down aging, says researcher

The scientist discusses several reasons, including fear of the actual and fictional side effects of rapamycin, everolimus and other clinically-approved drugs, arguing that no real side effects preclude their use as anti-aging drugs today.

17 Oct 2019

Osteoarthritis has no cure, but symptoms can be managed

Osteoarthritis can't be ignored. On a grand scale, it is the most common form of arthritis (which actually isn't a specific disease but rather a general term for inflammation in a joint), accounting for more cases than all the other forms combined. It affects an estimated 31 million Americans and is a leading cause of disability among adults.

10 Oct 2019

Aspirin may reduce adverse effects of air pollution exposure on lung function

A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs like aspirin may lessen the adverse effects of air pollution exposure on lung function.

3 Oct 2019

Study: Aspirin is not recommended for people who never had a heart attack or stroke

If you've never had a heart attack or stroke, you likely should not be taking aspirin to prevent them, according to new research.

3 Oct 2019

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug-coated stent in patients at high risk of bleeding and treated with one-month dual antiplatelet therapy (DAPT) found that both are clinically safe and effective.

27 Sep 2019

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

New data from the randomized, placebo-controlled TWILIGHT trial found that compared to ticagrelor plus aspirin, ticagrelor monotherapy reduces bleeding events without increasing the risk of death, myocardial infarction, or stroke in high-risk patients who have undergone successful percutaneous coronary intervention and completed three months of dual antiplatelet therapy.

27 Sep 2019

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.

27 Sep 2019

High-risk heart patients may not require long-term aspirin use after stent placement

High-risk patients undergoing coronary stent procedures may not require long-term aspirin use after stent placement, Mount Sinai researchers report in a groundbreaking study

26 Sep 2019

Study highlights need to educate women and medical community about risk factors of preeclampsia

Despite its crowded healthcare market and strong efforts to make healthcare more accessible to patients, New Jersey has one of the highest maternal mortality rates in the nation-;an issue so pertinent that First Lady Tammy Murphy created the Nurture NJ initiative to help reduce infant and maternal mortality.

20 Sep 2019

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.

18 Sep 2019

Aspirin News and Research

SDSU researchers show cancer-inhibiting potential of flavonoid metabolite

Medicinal plants: from genes to drugs

VA evaluates the effect of opioids, sedatives on veterans

Researchers investigate whether aspirin can decrease rate of intracranial aneurysm growth

Anti-inflammatory agents can safely, effectively reduce symptoms of major depression

Study aims to learn more about silent infarction, cognitive decline linked to silent stroke

Rapamycin is more effective at slowing down aging, says researcher

Osteoarthritis has no cure, but symptoms can be managed

Aspirin may reduce adverse effects of air pollution exposure on lung function

Study: Aspirin is not recommended for people who never had a heart attack or stroke

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

High-risk heart patients may not require long-term aspirin use after stent placement

Study highlights need to educate women and medical community about risk factors of preeclampsia

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

Rutgers cardiologist recommends individualized treatment with aspirin for primary prevention of CVD

Nano-sized bubbles in our body could effectively fight cancer

Benefits of restarting blood thinners outweigh the gastrointestinal‐related risks

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News